PATENT CLAIM ANALYSIS

Application Number: 16288374
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "006500"]

Abstract:
The present invention relates to a certain DPP-4 inhibitor for use in cardio- and/or renoprotective therapy, including in patients at high vascular risk.

Claim (Index 22):
The method of  claim 1 , wherein the patient is a type 2 diabetes patient whose diabetes is in early stage or in advanced stage.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 99.0
- Lexical Diversity: 1.04167
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15616974', '14928048', '15354053', '14633489', '13295174']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7611540536234266
- 35 USC 102 Novelty (BERT): 0.5994575389352117
- Combined Prediction Score: 0.7449844021546052
- Mean Citation Score: 402.637482
- Max Citation Score: 575.4381
- Similarity Product: 436.9396120625496

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test